I
nitiation of a T cell response requires T cell-dendritic cell (DC) interactions through two sets of receptors, as follows: TCR recognition of Ag in the form of peptides presented by the MHC molecules and binding of the costimulatory molecule CD28 on naive T cells to its ligands CD80 (B7.1) and CD86 (B7.2) expressed on mature DCs (1) (2) (3) . DCs are sentinels and normally reside in the tissues in an immature state without expressing CD80 and CD86 (4) . Following microbial infection, immature DCs take up and process Ags to present them as peptides with MHC (4, 5) . Immature DCs are also activated to express the costimulatory molecules through pathogen recognition receptors, such as TLR (6) , which recognize evolutionarily conserved microbial components or pathogen-associated molecular patterns (7) . By the time DCs migrate from the site of infection to the draining lymph nodes, they have matured, present antigenic peptides, and express costimulatory molecules (8, 9) . In the draining lymph node, the mature DCs activate cognate naive T cells by providing two stimulating signals (9) .
In addition to pathogen-associated molecular patterns, cytokines can also stimulate DC maturation and expression of CD80 and CD86 (10) . TNF-a and its family member lymphotoxin (LT) a are potent cytokines secreted by activated macrophages and T cells (5, 11, 12) and exert pleiotropic effects on inflammation and immunity through two receptors, TNFR1 (p55) and TNFR2 (p75), which are ubiquitously expressed by most nucleated cells (13, 14) . Treatment of DCs with TNF-a, but not LTa, in vitro leads to upregulation of surface expression of MHC class I, class II, CD80, and CD86, and an enhanced T cell stimulatory activity (12, 15) . Transgenic expression of TNF-a in DCs results in elevated levels of CD40, CD80, and ICAM-1 expression and induction of a stronger MLR (16) . In TNF-a-deficient (TNF-a 2/2 ) mice, DC maturation is impaired and T cell response is diminished following infection with a replication-deficient recombinant adenovirus (rAd) (17) . Adoptive transfer of Ag-primed wild-type DCs into TNF-a 2/2 mice rescues T cell response. Although in LTa
mice the number of DCs in the spleen was reduced, the observed deficiency is likely due to a lack of the membrane-bound LTa/b, but not soluble LTa, which signals through LTbR (18) (19) (20) (21) . Furthermore, the defective DC maturation and CD8 T cell responses in TNF-a 2/2 mice suggest that LTa does not replace TNF-a function in these processes. Together, these results suggest a critical role of TNF-a, but not LTa, in DC maturation in vivo.
The role of TNF-a/TNFR in DC maturation and T cell response, however, is more complex. In contrast to the diminished T cell response to rAd in TNF-a 2/2 mice (17), following Mycobacterium infection, Ag-specific CD8 T cells, as identified by peptide-MHC tetramer staining, are significantly elevated at 14 and 27 d postinfection (dpi) (22) . Similarly, following acute or chronic infections with lymphocytic choriomeningitis virus (LCMV), although the magnitude of virus-specific CD8 T cell response is similar between wild-type and TNFR1 T cell response to influenza virus infection (26) , and the defective CD8 T cell responses to LCMV most likely result from abnormal lymphoid architecture (27) .
Further complicating the delineation of the role of TNF-a/TNFR in DC maturation is the observation that T cells are required for efficient DC maturation, including CD80 and CD86 expression. In RAG1 2/2 mice, which are deficient in T cells, the number of DCs is significantly reduced, and the residual DCs are defective in expressing CD80 and CD86 and activating naive T cells (28) . Both the deficiency in DC number and function are restored by adoptive transfer of naive T cells into the RAG1 2/2 mice (29). Recently, B7-H1 (PD-L1) expressed by naive T cells is shown to condition immature DCs to undergo efficient maturation following stimulation by influenza virus (30) . Given the complex effects of TNFa/TNFR on CD8 T cell responses, it is possible that TNF-a or TNFRs may affect DC maturation and T cell response through multiple pathways.
In this study, we have constructed an attenuated mouse hepatitis virus A59 (MHV-A59) that infects mice, but does not cause apparent liver damage. By comparing DC maturation and CD8 T cell response in wild-type, TNFR1
2/2 , and TNFR2 2/2 mice following infection with the attenuated MHV-A59, we show that CD8 T cell response is impaired in the absence of TNFR1, but not TNFR2.
The impaired CD8 T cell response is associated with an impaired DC maturation and mobilization and can be corrected by adoptive transfer of wild-type DCs into TNFR1 2/2 mice. Furthermore, DC mobilization and maturation and CD8 T cell response in TNFR1 2/2 mice are also restored by adoptive transfer of TNFR1-expressing naive T cells. These findings suggest that TNFR1 mediates DC maturation through two mechanisms, as follows: a direct effect through TNFR1 expressed on immature DCs and an indirect effect through TNFR1 expressed on naive T cells. Our results also suggest a possible explanation for the divergent effects of TNF-a and TNFR deficiencies on CD8 T cell responses to different infections.
Materials and Methods

Viruses, mice, and infection
Wild-type MHV-A59, referred to as A59/WT, was engineered to express enhanced GFP (eGFP), ISQAVHAAHAEINEAGR (OVA 323-339 ), and SIYRYYGL (SIY), referred to as RA59/GOS. The recombinant RA59/ GOS was constructed by replacing open reading frame (ORF) 4 in A59/ WT with a sequence coding for eGFP-OVA-SIY fusion protein through targeted RNA recombination (31, 32) . Briefly, a 90-bp DNA fragment containing OVA-SIY sequences was cloned in frame into the 39 end of eGFP. The DNA fragment encoding eGFP-OVA-SIY fusion protein was then cut out and cloned into pMH54 plasmid (32, 33) 
Abs, tissue preparation, and flow cytometry
Mice were sacrificed and perfused with 5 ml PBS. Spleens were removed and gently homogenized through a nylon filter with a syringe plunger in RPMI 1640 medium supplemented with 2% FCS. RBCs in splenocyte suspension were lysed with 144 mM ammonium chloride and 17 mM TrisHCl (pH 7.4) solution. Single-cell suspension from liver was obtained by cutting liver tissue into pieces, followed by 1 mg/ml collagenase IV digestion at 37˚C for 30 min. The lysate was centrifuged at 50 3 g for 1 min to remove debris, resuspended in 5 ml 40% Percoll solution, and then layered over 5 ml 70% Percoll solution and centrifuged at 1500 3 g for 20 min without break at room temperature. Cells were removed from the interface, washed, and counted by trypan blue exclusion.
All Abs were purchased as direct conjugates. Anti-CD3 FITC, CD8 allophycocyanin, CD40 PE, CD80 PE, CD86 PE, and H-2K b :Ig fusion protein PE were from BD Biosciences. B220 FITC, Gr-1 FITC, CD11c FITC, and Thy1.1 (CD90.1) FITC were from eBiosciences. To load SIY peptide, SIY and H-2K b :Ig fusion protein at a molar ratio of 40:1 were incubated in 37˚C for 6 h. The SIY-K b was used within 1 wk. For staining, 0.5-2 3 10 6 cells from spleen and liver were incubated with anti-CD16/32 (Fc blocker) at 4˚C for 5 min and then incubated with a mixture of appropriate Abs at 4˚C for 30 min in PBS supplemented with 2% FCS and 0.1% azide. Dead cells were excluded by 7-aminoactinomycin D (7AAD) staining. Stained cells were analyzed on a FACSCalibur flow cytometer (BD Biosciences). Data analysis was carried out using FlowJo software (Tree Star, Ashland, OR).
For intracellular IFN-g and TNF-a staining, splenocytes and intrahepatic lymphocytes (1 3 10 6 ) were stimulated with or without SIY peptide (1 mg/ml) for 5 h at 37˚C in the presence of 10 U human rIL-2 and brefeldin A (Golgiplug; BD Pharmingen) in a total volume of 200 ml RPMI 1640 medium supplemented with 10% FCS. As positive controls, cells were stimulated by PMA and ionomycin in the presence of brefeldin A. As negative control, cells were cultured in medium only with brefeldin A. Cells were stained for surface expression of CD8 and SIY-K b dimer, then were fixed and permeabilized with the Cytofix/Cytoperm kit (BD Pharmingen) and stained with allophycocyanin-conjugated rat anti-mouse IFN-g mAb or FITC-conjugated rat anti-mouse TNF-a mAb. Cells were analyzed with a FACSCalibur cytometer.
Differentiation and transfer of DCs
Bone marrow cells from B6 mice were cultured at 4 3 10 5 cells/ml in RPMI 1640 supplemented with 10% FCS, 2-ME, L-glutamine, streptomycin, penicillin, and 20 ng/ml GM-CSF in 6-well plates (36) . At days 2 and 4, half of the culture medium was replaced with fresh medium. At day 7, nonadherent and loosely adherent cells were collected by gentle pipetting, and centrifuged at 400 3 g for 5 min. Cells were counted by trypan blue exclusion and analyzed for CD11c expression (∼90% CD11c + ) by flow cytometry. For adoptive transfer, 8 3 10 5 cells in 200 ml PBS were administrated per mouse by tail vein injection.
Purification and transfer of T cells
Total T cells were purified from lymph nodes of B6 mice (Thy1.1 + ) by negative depletion using FITC-conjugated anti-CD11c, B220, or Gr-1 Abs, followed with anti-FITC magnetic beads (Miltenyi Biotec). CD4
+ and CD8 + T cells were purified from lymph nodes of B6 mice by positive selection using anti-CD4-or anti-CD8-conjugated magnetic beads. Purified cells were counted and analyzed for CD3 by flow cytometry. 
Statistical analyses
Statistical significance between groups was assessed by Student t test using Prism 5 software (GraphPad Software). A p value ,0.05 was considered significant.
Results
Construction and characterization of recombinant MHV
Although a CD8 epitope, RCQIFANI (37), has been identified in wild-type MHV-A59 (A59/WT), its binding to MHC class I K b is weak. K b tetramer loaded with RCQIFANI failed to stain CD8 T cells in the spleen of MHV-infected C57BL/6 (B6) mice (data not shown). To facilitate studying T cell responses to A59/WT, we constructed a recombinant MHV-A59 expressing eGFP fused to a CD4 epitope, ISQAVHAAHAEINEAGR (OVA 323-339 ), and a CD8 epitope, SIYRYYGL (SIY). The recombinant MHV, referred to as RA59/GOS, was constructed by targeted RNA recombination replacing a nonessential gene, ORF4, with sequence encoding eGFP-OVA-SIY fusion protein (Fig. 1A , see Materials and Methods). Recombinant virus was selected via eGFP-positive cells (Fig. 1B) and further plaque purified.
The recombinant RA59/GOS virus was further characterized for its replication in vitro and infection in mice. Murine fibroblasts 17Cl-1 were inoculated with 5 3 10 5 PFU of either A59/WT or RA59/GOS (multiplicity of infection [MOI] = 1), and virus titer in the culture supernatants was measured every 4 h for the next 24 h. The titer of A59/WT increased steadily, reaching a peak level of 10 8 PFU/ml at ∼20 h postinfection (Fig. 1C) . In contrast, the titer of RA59/GOS only reached 10 6 PFU/ml 24 h postinfection, indicating a reduction of replication capacity by ∼100-fold. Furthermore, B6 mice were inoculated i.p. with A59/WT or RA59/ GOS, and virus titers were measured in the liver 1, 3, and 5 dpi. Following inoculation with 5 3 10 5 PFU A59/WT, virus was readily detected in the liver at all three time points, peaking at 3 dpi (Fig. 1D) . In contrast, RA59/GOS virus was detected in the liver of inoculated mice only at 1 dpi and only when 1 3 10 6 PFU was used for the inoculation. No virus was detected at 3 or 5 dpi or when lower doses of virus were inoculated. Correlating with virus replication, elevated levels of serum alanine aminotransferase (ALT) were detected in B6 mice infected with A59/WT virus at 1, 3, and 5 dpi (Fig. 1E ), whereas no elevated ALT level was detected in RA59/GOS-inoculated mice at any day or virus doses. Taken together, these results suggest that RA59/GOS is an attenuated virus with dramatically reduced capacity to replicate in cultured cells and mice.
RA59/GOS induces CD8 T cell responses in a dose-dependent manner
To study CD8 T cell response to MHV infection, we inoculated B6 mice with 10 2 , 10 4 , or 10 6 PFU RA59/GOS. At 7 dpi, SIY-specific (Fig. 2A) . Similar background level of SIY-positive CD8 T cells was detected in the spleen and liver of RA59/GOS-infected mice when H-2K b :Ig fusion protein used for staining was not loaded with SIY peptide (Fig. 2A, far  right panel) . In contrast, the frequency of SIY-positive CD8 T cells was increased at least 10-fold over the background level in the spleen and liver of RA59/GOS-infected mice that were stained with both anti-CD8 and SIY-K b . Notably, the frequency of SIY-K b -positive CD8 T cells increased with the increasing inoculation virus doses. Similarly, the total numbers of SIY-positive CD8 T cells in the spleen and liver increased with the increasing inoculation virus doses (Fig. 2B) . In addition, a significant fraction of SIY-K b -positive CD8 T cells from both the spleen and liver was induced to express IFN-g or TNF-a by SIY peptide in vitro (Fig.  2C) . These results suggest that attenuated RA59/GOS virus can cause infection in mice, but probably does not replicate significantly, resulting in functional CD8 T cell responses proportional to the doses of inoculating virus.
Defective CD8 T cell response to RA59/GOS in TNFR1-deficient mice
To investigate the effect of TNFR in CD8 T cell response to MHV, we compared SIY-specific CD8 T cell responses to RA59/GOS among B6 mice, B6 mice deficient in TNFR1 (TNFR1 2/2 ), and B6 mice deficient in TNFR2 (TNFR2 2/2 ). At 7 dpi, similar frequency and number of SIY-specific CD8 T cells were detected in the spleen and liver of B6 and TNFR2 2/2 mice (Fig. 3A, 3B ).
However, only background level of SIY-specific CD8 T cells was detected in the spleen and liver of TNFR1 2/2 mice.
To exclude the possibility that CD8 T cell response in TNFR1 2/2 mice was delayed, the frequency and total number of SIY-specific CD8 T cells were measured in the spleen and liver 11 dpi. Again, whereas similarly robust SIY-specific CD8 T cell responses were detected in the spleen and liver of B6 and TNFR2 2/2 mice, no significant SIY-specific CD8 T cell response was detected in TNFR1 2/2 mice (Fig. 3C, 3D ). These results show that TNFR1, but not TNFR2, is required for efficient CD8 T cell response to MHV infection.
Impaired DC mobilization and maturation in TNFR1-deficient mice following RA59/GOS infection
Because of the critical role of DCs in mediating CD8 T cell responses, we determined DC numbers and maturation status in TNFR1 mice expressed CD40, CD80, CD86, or class I (Fig. 4A, 4B ; p , 0.05). More dramatically, whereas the number of CD11c + DCs was similar in the spleen or liver between PBS-injected B6 and TNFR1 2/2 mice (Fig. 4C) , the number of CD11c + DCs was increased ∼2-fold in both spleen and liver of B6 mice following RA59/GOS infection. However, the number of CD11c + DCs was not increased at all in the spleen and liver of TNFR1 2/2 mice following RA59/ GOS infection. Thus, in the absence of TNFR1, DC mobilization and maturation are impaired following RA59/GOS infection. Next, we determined whether SIY-specific CD8 T cell response to RA59/GOS infection can be rescued by transfer of TNFR1-expressing DCs into TNFR1 2/2 mice. GM-CSF-induced bone marrow DCs from B6 mice were adoptively transferred into TNFR1 2/2 mice, followed by infection with RA59/GOS and analysis at 7 dpi. Without DC transfer, virtually no SIY-specific CD8 T cells were detected in the spleen or liver of TNFR1 2/2 mice. With DC transfer, SIY-specific CD8 T cells were detected in the spleen and liver of TNFR1 2/2 mice (Fig. 5) . Statistically, there was no difference in both the frequency and the number of SIYspecific CD8 T cells in the spleen or liver between B6 mice and TNFR1 2/2 mice that were transferred with DCs. These results show that the impaired DC maturation and mobilization is a major factor contributing to the defective CD8 T cell response to RA59/ GOS infection in TNFR1 2/2 mice.
Transfer of TNFR1-expressing T cells also rescues endogenous CD8 T cell response to RA59/GOS in TNFR1-deficient mice
We also tested whether TNFR1-expressing T cells can rescue CD8 T cell response to RA59/GOS infection in TNFR1 (Fig. 6B, 6C ). Statistically, there was no difference in both the frequency and the number of SIY-specific Thy1.1 2 CD8 T cells in the spleen or liver between B6 mice and TNFR1 2/2 mice transferred with T cells.
Furthermore, when purified CD4 and CD8 T cells were transferred separately into TNFR1 2/2 mice, endogenous CD8 T cell responses to MHV were also elevated to similar levels as in B6 mice (Fig. 6D) . These results show that transfer of TNFRexpressing T cells into TNFR1 2/2 mice also restores the endogenous CD8 T cell response to RA59/GOS infection. 
TNFR1-expressing T cells restore DC mobilization and maturation in TNFR1-deficient mice
We further determined whether DC mobilization and maturation in TNFR1 2/2 mice were restored by adoptive transfer of TNFR1-expressing T cells. Purified Thy1.1 + T cells were transferred into TNFR1 2/2 mice (5 3 10 6 cells per recipient), followed by RA59/ GOS infection and analysis for CD11c, CD40, CD80, CD86, and MHC I at 3 dpi. As shown in Fig. 4A and 4B, DCs from T celltransferred TNFR1 2/2 mice upregulated CD40, CD80, CD86, and MHC I to the similar levels as those in B6 mice. In addition, the numbers of DCs in the spleen and liver were restored to the similar levels as those in B6 mice (Fig. 4C) . These results show that transferred T cells rescue the virus-specific CD8 T cell response in TNFR1 2/2 mice through DC activation and mobilization.
Discussion
Studies have shown a critical role of TNF-a in DC maturation both in vitro and in vivo (12, (15) (16) (17) . Although LTa also binds to TNFR1 and TNFR2, its effect on DC accumulation and/or homeostasis in the spleen is primarily through signaling via LTbR by membrane LTa/b, but not soluble LTa (18) (19) (20) (21) . Consistently, LTa 2/2 mice produce delayed, but effective CD8 T cell responses to influenza virus infection (26) , and the defective CD8 T cells responses to LCMV most likely result from abnormal lymphoid architecture (27) . Furthermore, the defective DC maturation and CD8 T cell responses in TNF-a 2/2 mice suggest that LTa does not replace TNF-a function in these processes. These findings suggest that signaling through TNFR by soluble LTa is unlikely critical for DC maturation or CD8 T cell responses. Nevertheless, because LTa 2/2 mice lack both soluble LTa and membrane LTa/ b and because there is no reagent for selectively blocking soluble LTa, current studies have not conclusively ruled out an essential involvement of soluble LTa in DC maturation and CD8 T cell responses.
Results presented in this work reveal two distinct mechanisms by which TNFR stimulates DC maturation and initiates T cell response following MHV infection. First, our findings suggest that TNF-a TNF-a also directly stimulates DC maturation through TNFR1 expressed on immature DCs. Second, our results reveal an alternative T cell-dependent pathway by which TNF-a may stimulate DC maturation and CD8 T cell response in vivo. We found that in TNFR1 2/2 mice DC mobilization and maturation and CD8 T cell response to the attenuated MHV are also restored by adoptive transfer of TNFR1-expressing naive T cells. Because in these mice only the transferred T cells can respond to TNF-a, restoration of DC maturation and mobilization and response by endogenous CD8 T cells must go through the transferred T cells. Macrophages play a critical role in the clearance of MHV (39) . It can be envisioned that TNF-a secreted by activated macrophages could stimulate the transferred naive T cells, resulting in expression of molecules that can in turn stimulate DC mobilization and maturation. For example, CD40L is expressed by activated T cells and can engage CD40 expressed on immature DCs to stimulate DC maturation (40) . Nevertheless, the molecular mechanism mediating the T cell-dependent pathway of DC maturation and mobilization has yet to be elucidated. Our results also provide a possible explanation for the apparently contradictory results of CD8 T cell responses to different infections in TNF-a
, and TNFR1 2/2 and TNFR2 2/2 double-knockout mice (17, 23, 29) . The recombinant RA59/GOS was constructed by replacing a 283-bp fragment of ORF4 with eGFP-OVA-SIY. The resulting virus is attenuated based on the observation that the virus titer was reduced .100-fold in both 17C1-1 cells and mice when compared with the wild-type MHV-A59 virus (Fig. 1B, 1C ). In addition, the duration of virimia was reduced to the first day postinfection with RA59/GOS, whereas virimia was detected for 3 d postinfection with RA59/ WT (Fig. 1C) . Consistent with the minimal viral replication, no serum ALT was detected following inoculation of RA59/GOS. However, virus infection and limited translation occur because CD8 T cell response to SIY can be detected in a dose-dependent manner (Fig. 2) . Das Sarma et al. (32) have reported a recombinant MHV-A59 in which ORF4 was replaced with GFP. The resulting virus replicated similarly as wild-type A59 in vitro. However, Sperry et al. (41) reported that single amino acid substitutions in ORF1b-nsp14 and ORF2a of the MHV are attenuating in vivo. The difference between the two recombinant viruses is the addition of OVA-SIY sequences to the GFP sequences in our virus, resulting in an insert of 860-bp fragment in our virus versus an insert of 720 bp in Das Sarma's virus. As the replaced fragment of ORF is only 283 bp, the increased insert size could have interfered with virus replication, resulting in an attenuated RA59/GOS. It is notable that T cell response is impaired in TNF-a 2/2 mice following infection with a replication-defective rAd (17) and in TNFR1 2/2 mice following infection with an attenuated MHV.
In contrast, T cell responses were all enhanced in TNF-a 2/2 or TNFR 2/2 mice following acute or chronic infection with replication-competent pathogens, such as LCMV, influenza virus, and Mycobacterium (17, (22) (23) (24) (25) . Studies have shown that DCs can be stimulated to mature independent of TNF-a (42), probably through direct interaction between microbial components and TLRs (6) or other pathogen recognition receptors (43, 44) . The TNF-a-independent pathway of DC maturation is more likely to occur when pathogen can replicate, whereas the replicationdefective or highly attenuated pathogens may not produce sufficient amount of microbial components to directly engage TLRs and other pathogen recognition receptors to active DCs directly. Thus, T cell response is selectively impaired in TNF-a 2/2 or TNFR1 2/2 mice only in response to infection with replicationdefective rAd or highly attenuated MHV. It is also possible that different pathogens, such as MHV, rAd, LCMV, influenza virus, and Mycobacterium, express different microbial components, infect different cell types in mice, and have different replication cycles; these differences may also contribute to the observed different outcomes of CD8 T cell responses in TNF-a-or TNFRdeficient mice. In summary, our results show that in vivo TNFR1 mediates TNFa-dependent DC maturation either through a direct binding of TNF-a to TNFR1 on immature DCs or through an indirect T celldependent pathway. The divergent CD8 T cell responses to different infections in TNF-a-and TNFR-deficient mice may also relate to the pathways by which DCs are activated.
